SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC - Quaterly Results

06 Feb 2026 Evaluate
The revenue for the December 2025 quarter is pegged at Rs. 4579.41 millions against Rs. 4588.62 millions recorded during the year-ago period.A slender decline of -25.41% was recorded to Rs. 271.87  millions from Rs. 364.48 millions in the corresponding previous quarter.Operating profit for the quarter ended December 2025 rose to 716.78 millions as compared to 645.90 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 4579.41 4588.62 -0.20 15619.64 15881.07 -1.65 20701.12 19161.87 8.03
Other Income 220.70 186.45 18.37 785.68 814.76 -3.57 1055.18 1032.16 2.23
PBIDT 716.78 645.90 10.97 3044.05 3415.14 -10.87 4257.65 4416.74 -3.60
Interest 11.16 9.44 18.22 34.26 33.07 3.60 44.88 40.00 12.20
PBDT 497.73 636.46 -21.80 2801.90 3382.07 -17.15 4212.77 4376.74 -3.75
Depreciation 147.51 133.24 10.71 447.92 380.77 17.64 536.06 397.29 34.93
PBT 350.22 503.22 -30.40 2353.98 3001.30 -21.57 3676.71 3979.45 -7.61
TAX 78.35 138.74 -43.53 565.46 747.20 -24.32 940.46 907.82 3.60
Deferred Tax -14.65 4.64 -415.73 12.46 53.10 -76.53 90.46 51.63 75.21
PAT 271.87 364.48 -25.41 1788.52 2254.10 -20.65 2736.25 3071.63 -10.92
Equity 162.81 162.81 0.00 162.81 162.81 0.00 162.81 162.81 0.00
PBIDTM(%) 15.65 14.08 11.20 19.49 21.50 -9.37 20.57 23.05 -10.77

FDC Share Price

364.70 0.95 (0.26%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×